[Immunohistochemical detection of hepatitis C virus antigen from hepatocellular carcinoma]

F Zhou1, L Zhao, C Liu

  • 1Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041.

Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|September 6, 2002
PubMed

Insights

Hepatitis C virus (HCV) infection is present in some liver cancer (HCC) cases in China. This suggests HCV may be a viral risk factor for HCC, alongside hepatitis B virus (HBV).

Area of Science:

  • Hepatology
  • Virology
  • Oncology

Context:

  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • Hepatitis B virus (HBV) is a known risk factor for HCC.
  • The role of Hepatitis C virus (HCV) in HCC development in China requires further investigation.

Purpose:

  • To investigate the prevalence of HCV infection and HCV antigen (HCAg) expression in HCC tissues.
  • To simultaneously detect HCAg and Hepatitis B virus surface antigen (HBsAg) in HCC samples.
  • To assess the potential role of HCV as a viral risk factor in HCC genesis.

Summary:

  • Immunohistochemistry was used to analyze 40 HCC tumor tissues.
  • HCV antigen (HCAg) was detected in 17.5% of cases, while HBsAg was found in 70%.
  • Co-infection of HBsAg and HCAg was observed in 15% of patients, with a small percentage showing HCAg positivity alone.

Impact:

  • This study indicates that HCV infection occurs in a subset of HCC patients in China.
  • HCV may represent an additional viral risk factor for HCC development.
  • Findings contribute to understanding the multifactorial etiology of HCC in the Chinese population.